Scpharmaceuticals Stock Price on December 31, 2024

SCPH Stock  USD 3.56  0.06  1.66%   
If you're considering investing in Scpharmaceuticals Stock, it is important to understand the factors that can impact its price. As of today, the current price of Scpharmaceuticals stands at 3.56, as last reported on the 8th of January, with the highest price reaching 3.74 and the lowest price hitting 3.50 during the day. Scpharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0565, which indicates the firm had a -0.0565% return per unit of risk over the last 3 months. Scpharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Scpharmaceuticals' Coefficient Of Variation of (1,770), variance of 12.7, and Risk Adjusted Performance of (0.04) to confirm the risk estimate we provide.
  
Scpharmaceuticals Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0565

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsSCPH

Estimated Market Risk

 3.56
  actual daily
31
69% of assets are more volatile

Expected Return

 -0.2
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.06
  actual daily
0
Most of other assets perform better
Based on monthly moving average Scpharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Scpharmaceuticals by adding Scpharmaceuticals to a well-diversified portfolio.

Related Headline

Monopar Therapeutics Headline on 31st of December 2024

Filed transaction by Monopar Therapeutics Other: Acting Chief Medical Officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Scpharmaceuticals Valuation on December 31, 2024

It is possible to determine the worth of Scpharmaceuticals on a given historical date. On December 31, 2024 Scpharmaceuticals was worth 3.53 at the beginning of the trading date compared to the closed value of 3.54. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Scpharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Scpharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Scpharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Scpharmaceuticals' related companies.
 Open High Low Close Volume
  3.40    3.51    3.33    3.50    403,432  
12/31/2024
  3.53    3.60    3.45    3.54    304,996  
  3.60    3.70    3.50    3.57    301,159  
Backtest Scpharmaceuticals  |  Scpharmaceuticals History  |  Scpharmaceuticals Valuation   PreviousNext  
Open Value
3.53
3.54
Closing Value
14.22
Upside

Scpharmaceuticals Trading Date Momentum on December 31, 2024

On January 02 2025 Scpharmaceuticals was traded for  3.57  at the closing time. The top price for the day was 3.70  and the lowest listed price was  3.50 . The trading volume for the day was 301.2 K. The trading history from January 2, 2025 was a factor to the next trading day price growth. The trading price change against the next closing price was 0.85% . The trading price change against the current closing price is 0.85% .

Scpharmaceuticals Fundamentals Correlations and Trends

By evaluating Scpharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Scpharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Scpharmaceuticals financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Scpharmaceuticals Stock history

Scpharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Scpharmaceuticals is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Scpharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Scpharmaceuticals stock prices may prove useful in developing a viable investing in Scpharmaceuticals
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. scPharmaceuticals Inc. was incorporated in 2013 and is headquartered in Burlington, Massachusetts. SC Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 26 people.

Scpharmaceuticals Stock Technical Analysis

Scpharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Scpharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Scpharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Scpharmaceuticals Period Price Range

Low
January 8, 2025
0.00  NaN%
High

 0.00 

     

 0.00 

Scpharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Scpharmaceuticals January 8, 2025 Market Strength

Market strength indicators help investors to evaluate how Scpharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Scpharmaceuticals shares will generate the highest return on investment. By undertsting and applying Scpharmaceuticals stock market strength indicators, traders can identify Scpharmaceuticals entry and exit signals to maximize returns

Scpharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Scpharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Scpharmaceuticals Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Scpharmaceuticals to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Scpharmaceuticals Stock analysis

When running Scpharmaceuticals' price analysis, check to measure Scpharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scpharmaceuticals is operating at the current time. Most of Scpharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Scpharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scpharmaceuticals' price. Additionally, you may evaluate how the addition of Scpharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Share Portfolio
Track or share privately all of your investments from the convenience of any device
FinTech Suite
Use AI to screen and filter profitable investment opportunities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals